FluoGuide
54 SEK 0%5 investors are following this company
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUO
Daily low / high price
52 / 54
SEK
Market cap
659.25M SEK
Turnover
45.32K SEK
Volume
852
Latest videos
Financial calendar
Interim report
30.05.2024
Interim report
29.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Life Science IVS | 17.7 % | 17.7 % |
Wexotec ApS | 12.4 % | 12.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Fluoguide: Wrap up from interview with CEO Morten Albrechtsen
Minutes from Annual General Meeting in FluoGuide A/S
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools